Pharmacokinetics and Pharmacodynamics of MTR105 in Hypotensive Cardiac Surgery Patients
Status:
Withdrawn
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, pharmacokinetic and the pharmacodynamic
effects of escalating doses of MTR105 while weaning from bypass in a hypotensive population
of cardiac surgery patients.